Sign in
Join
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Home
Tags
NASDAQ:ABUS
Tag: NASDAQ:ABUS
Arbutus Biopharma Corporation (NASDAQ:ABUS) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
March 15, 2019
0
Arbutus Biopharma Corporation (NASDAQ:ABUS) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
November 27, 2018
0
Arbutus Biopharma Corp (NASDAQ:ABUS) gets upgraded to Buy by B. Riley...
ME Staff
-
October 16, 2018
0
Arbutus Biopharma Corp (NASDAQ:ABUS) gets upgraded to Neutral by Wedbush with...
ME Staff
-
October 15, 2018
0
Arbutus Biopharma Corp (NASDAQ:ABUS) gets upgraded to Hold by Wedbush with...
ME Staff
-
October 15, 2018
0
Arbutus Biopharma Corp (NASDAQ:ABUS) price target lowered to $6.50 by Chardan...
ME Staff
-
October 12, 2018
0
Arbutus Biopharma Corp (NASDAQ:ABUS) gets downgraded to Underperform by Wedbush
ME Staff
-
October 9, 2018
0
Arbutus Biopharma Corp (NASDAQ:ABUS) price target raised to $11.50 by B....
ME Staff
-
August 13, 2018
0
Arbutus Biopharma Corp (NASDAQ:ABUS) had its Outperform rating reiterated by Chardan...
ME Staff
-
July 16, 2018
0
Analyst Activity – Chardan Capital Reiterates Buy on NASDAQ:ABUS – Arbutus...
ME Staff
-
May 7, 2018
0
1
2
3
4
Page 1 of 4
/* */
// AST – IMS - [MarketExclusive_ROS]
